India hopes Hyderabad 'pharma city' will break China's grip on industry

India's ability to secure not just its own drug supply but that of Africa, the Americas and Europe is at stake

Pharma city

Inside a laboratory at Laurus Labs’ research and development center in Genome Valley | Photo: Bloomberg

On the edge of Hyderabad in southern India, a vast patch of arid shrub-land the size of about 14,000 football fields is becoming a testing ground for a model that

Also Read

Indian Oil Corporation, Adani Total Gas top bidders for city gas licenses

Budget 2022: Pharma industry seeks enhanced funds for healthcare sector

NPPA fixes price caps for 12 anti-diabetic medicines

Portugal to spend 32.7mn euros on Covid-19 medicines

India reiterates concern on terrorist entities getting chemical weapons

FinMin asks Infosys to work on ways to access taxpayers' data accurately

Electric three-wheeler market: Can Bajaj Auto storm in and become king?

SC stays NCLAT order in DHFL case on Piramal's appeal

India's 'Unicorn couple' eyes first start-up IPO within a year

Combined m-cap of all listed Adani Group firms crosses Rs 16 trillion

First Published: Apr 12 2022 | 8:10 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to